# Program 1 Architecture Review Track Phase E - Human-in-the-Loop Responsibility and Clinical Accountability Boundary

Status: documentation-only, synthetic-only, non-production, non-runtime, pre-implementation, conceptual clinical accountability boundary. Not an implementation authorization, not a clinical accountability implementation, and not a clinical validation module.

## Purpose

Program 1 Architecture Review Track Phase E defines a conceptual human-in-the-loop responsibility boundary and clinical accountability model for any possible future Program 1 clinical discussion.

Phase E follows Architecture Review Track Phase A, Phase B, Phase C, and Phase D. It is not Phase Z+1 and is not a return to the Phase V-Z governance/prototype sequence.

Program 1 remains in pre-implementation hold.

## Track continuity

Phase A established the synthetic-only architecture boundary. Phase B established conceptual module separation. Phase C established conceptual synthetic data-flow traces. Phase D established a conceptual read-only reference boundary and strict non-mutation model. Phase E narrows the clinical safety question: any future clinical use concept would require accountable human review and clinician-controlled decision-making, but Phase E does not implement or authorize that model.

## Scope

- Human-in-the-loop responsibility model.
- Clinical accountability boundary.
- Autonomous clinical behavior prohibition.
- Clinician review and decision separation.
- Patient instruction and communication prohibition.
- Accountability dependency map.
- Clinical boundary matrix.

## Non-scope

Phase E does not add runtime code, tests, helpers, scripts, imports, services, database migrations, API endpoints, UI flows, schedulers, task runners, integrations, data connectors, real-data ingestion, PHI/PII processing, read-only runtime access, database queries, EHR/EMR access, clinical decision execution, autonomous diagnosis, autonomous treatment, patient instruction delivery, clinician-facing executable recommendations, runtime auth/authz/RBAC, runtime audit logging, patient messaging, appointment mutation, workflow enforcement, Task engine, Outcome Evidence, clinical write workflows, approval/clearance/override runtime capability, production-readiness claim, or go-live authorization.

## Safety boundaries

Phase E is documentation-only, synthetic-only, non-production, non-runtime, pre-implementation, conceptual only, not an implementation authorization, not a production-readiness review, not a clinical deployment review, not a clinical accountability implementation, and not a clinical validation module.

Phase E does not approve production use, real patient data, PHI/PII processing, live clinical deployment, clinical validation, operational clearance, go-live, runtime implementation, runtime read-only access, runtime data flow, database queries, EHR/EMR access, patient record viewing, real-data inspection, clinical decision execution, autonomous diagnosis, autonomous treatment, clinician-facing executable recommendation workflow, patient instruction delivery, patient messaging, appointment mutation, workflow enforcement, or approval/clearance/override behavior.

## Phase A/B/C/D input summary

Phase A established synthetic-only architecture boundaries, permitted future discussion areas, prohibited runtime paths, data classification preview, read-only vs write-capable conceptual distinction, human-in-the-loop responsibility preview, and a future approval dependency map.

Phase B established conceptual module separation, the synthetic documentation layer boundary, future read-only layer boundary, future clinical review layer boundary, prohibited write-capable layer boundary, prohibited patient communication boundary, prohibited appointment mutation boundary, deferred security/audit/authorization layer, and prohibited coupling map.

Phase C established the synthetic entity model, conceptual data-flow model, allowed synthetic trace paths, prohibited real-data flow paths, read-only conceptual flow boundary, write-back and mutation prohibition trace, security/audit/auth conceptual flow limits, and boundary trace matrix.

Phase D established the conceptual read-only reference boundary, non-mutation model, prohibited read access paths, prohibited write-back and mutation paths, read-only vs operational access distinction, and synthetic reference trace matrix.

## Human-in-the-loop responsibility model

A future conceptual responsibility model would require:

- Accountable licensed clinician.
- Explicit human review.
- Clinician-controlled interpretation.
- Clinician-controlled decision-making.
- No autonomous diagnosis.
- No autonomous treatment.
- No automatic patient instruction.
- No automatic workflow enforcement.
- No automatic appointment mutation.
- No automatic task assignment.
- No automatic approval/override behavior.

This is only a future conceptual boundary. It is not implemented and not authorized by Phase E.

## Clinical accountability boundary

Any future clinical use would require a documented accountability model before implementation discussion. Required areas include accountable clinician role, reviewer responsibility, decision ownership, escalation responsibility, documentation responsibility, patient communication responsibility, error/incident responsibility, rollback responsibility, and governance review dependency.

Phase E does not assign operational responsibility and does not create clinical workflows.

## Autonomous clinical behavior prohibition

Phase E explicitly prohibits autonomous diagnosis, autonomous treatment recommendation execution, autonomous triage, autonomous patient instruction, autonomous medication instruction, autonomous appointment changes, autonomous escalation, autonomous clinical note generation into records, autonomous task creation, autonomous Outcome Evidence creation, and autonomous approval, clearance, or override.

## Clinician review and decision separation

Phase E permits only documentation of conceptual separation between:

- Synthetic architectural placeholder.
- Future informational reference.
- Clinician review.
- Clinician decision.
- Clinical action.
- Patient communication.
- Record mutation.

Phase E does not permit any runtime transition between these stages.

## Patient instruction and communication prohibition

Phase E does not permit patient messaging, patient reminders, patient education delivery, patient portal output, automatic patient summaries, staff-mediated automatic patient instruction, treatment instructions to patients, preparation instructions to patients, or appointment instructions to patients.

## Accountability dependency map

| Accountability area | Current Phase E status | Unresolved dependency | Prohibited current action | Required future review | Current decision |
| --- | --- | --- | --- | --- | --- |
| Clinician accountability | Conceptual only | Accountable clinician model | Assign operational responsibility | Clinical governance review | Deferred |
| Clinical safety review | Not performed | Safety review process | Claim clinical validation | Clinical safety review | Deferred |
| Privacy/legal review | Not performed | Real-data and PHI/PII governance | Process patient data | Privacy/legal review | Deferred |
| Human-in-the-loop model | Conceptual only | Operational responsibility model | Implement clinical workflow | Clinical governance review | Deferred |
| Decision ownership | Conceptual only | Decision ownership policy | Execute decisions | Clinical accountability review | Deferred |
| Patient communication responsibility | Conceptual only | Communication governance | Send or trigger patient instructions | Patient communication review | Prohibited |
| Incident response | Conceptual only | Incident ownership model | Activate live incident workflow | Operational governance review | Deferred |
| Rollback responsibility | Conceptual only | Rollback model | Execute rollback | Operational governance review | Deferred |
| Validation evidence | Not produced | Validation plan and evidence | Claim validation | QA/validation review | Deferred |
| Audit responsibility | Conceptual only | Audit ownership model | Capture runtime audit events | Audit/security review | Deferred |
| Authorization responsibility | Conceptual only | Authorization ownership model | Enforce runtime access | Security review | Deferred |
| Deployment governance | Not performed | Deployment governance model | Authorize deployment | Production governance review | Deferred |

## Clinical boundary matrix

| Clinical concept | Allowed in Phase E | Prohibited in Phase E | Runtime status | Patient-facing status | Clinician-facing status | Future dependency | Current decision |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Synthetic clinician review placeholder | Text-only concept | Clinical workflow | None | None | Conceptual only | Clinical governance review | Allowed as docs only |
| Future clinician review concept | Boundary discussion | Runtime review workflow | Not implemented | None | Not executable | Clinical accountability model | Deferred |
| Clinical decision concept | Boundary discussion | Decision execution | Not implemented | None | Not executable | Licensed clinician accountability | Deferred |
| Diagnosis concept | Prohibition discussion | Diagnosis generation or writing | Prohibited | None | Not executable | Clinical safety review | Prohibited |
| Treatment concept | Prohibition discussion | Treatment recommendation execution | Prohibited | None | Not executable | Clinical safety review | Prohibited |
| Triage concept | Prohibition discussion | Autonomous triage | Prohibited | None | Not executable | Clinical safety review | Prohibited |
| Patient instruction concept | Prohibition discussion | Patient instruction delivery | Prohibited | Prohibited | Not executable | Patient communication governance | Prohibited |
| Appointment decision concept | Prohibition discussion | Appointment mutation | Prohibited | Prohibited | Not executable | Appointment governance review | Prohibited |
| Clinical note concept | Prohibition discussion | Clinical note generation into records | Prohibited | None | Not executable | Clinical accountability review | Prohibited |
| Escalation concept | Boundary discussion | Autonomous escalation | Not implemented | None | Not executable | Incident/escalation governance | Deferred |
| Incident response concept | Boundary discussion | Live incident tooling | Not implemented | None | Not executable | Operational governance review | Deferred |
| Approval/override concept | Prohibition discussion | Approval or override capability | Prohibited | None | Not executable | Governance authorization | Prohibited |

## Explicit non-approval statement

Phase E does not approve implementation, production use, real-data use, PHI/PII processing, clinical deployment, go-live, runtime data flow, read-only runtime access, database access, EHR/EMR access, patient record viewing, operational access, clinical decision execution, autonomous diagnosis, autonomous treatment, patient instruction delivery, patient messaging, appointment mutation, workflow enforcement, clinical write workflows, runtime authorization, runtime audit logging, or approval/clearance/override capability.

## Next-step decision

Recommended next phase: `Program 1 Architecture Review Track Phase F - Security, Authorization, and Audit Conceptual Boundary`.

If opened, Phase F should remain documentation-only and synthetic-only. Phase F must not introduce runtime security enforcement, RBAC, audit capture, approval gates, override gates, or production access.

## Closure statement

Architecture Review Track Phase E closes with Program 1 still in pre-implementation hold. No runtime behavior, clinical decision execution, autonomous diagnosis/treatment, patient instruction delivery, patient messaging, appointment mutation, real-data ingestion, PHI/PII processing, mutation behavior, approval/clearance/override capability, production approval, clinical deployment, or go-live authorization is created.
